You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
McKinsey
Johnson and Johnson
Moodys

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

VALSARTAN AND HYDROCHLOROTHIAZIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Valsartan And Hydrochlorothiazide patents expire, and what generic alternatives are available?

Valsartan And Hydrochlorothiazide is a drug marketed by Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Prinston Inc, Watson Labs Teva, and Zydus Pharms. and is included in nine NDAs.

The generic ingredient in VALSARTAN AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; valsartan. There are thirty-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.

Drug patent expirations by year for VALSARTAN AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for VALSARTAN AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Farma de Colombia SAPhase 3
Damanhour UniversityN/A
Tehran University of Medical SciencesPhase 3

See all VALSARTAN AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for VALSARTAN AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for VALSARTAN AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms VALSARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; valsartan TABLET;ORAL 203000-001 Mar 15, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Prinston Inc VALSARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; valsartan TABLET;ORAL 206083-002 Feb 8, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms VALSARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; valsartan TABLET;ORAL 203000-005 Mar 15, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc VALSARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; valsartan TABLET;ORAL 078020-004 Sep 21, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Prinston Inc VALSARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; valsartan TABLET;ORAL 206083-003 Feb 8, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
McKinsey
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.